Formula Act of 2022

Hozzl · 2022-12-30T00:04:05Z

Explore the details of House Bill 7718 Formula Act of 2022 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/30/2022, 12:04 AM

Summary of Bill HR 7718

Bill 117 HR 7718, also known as the Formula Act of 2022, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to establish a new formula for distributing federal funds to states and local governments.

The bill aims to create a more equitable and efficient system for allocating funds based on various factors such as population size, poverty rates, and infrastructure needs. This new formula is intended to ensure that resources are distributed in a way that addresses the unique needs of each state and community.

Additionally, the Formula Act of 2022 includes provisions for increased transparency and accountability in the distribution of federal funds. This includes requirements for regular reporting on how funds are being used and the impact they are having on the intended recipients. Overall, the Formula Act of 2022 seeks to improve the effectiveness of federal funding distribution and ensure that resources are being allocated in a fair and equitable manner. It is currently being debated in Congress and may undergo further revisions before being voted on.

Congressional Summary of HR 7718

Formula Act of 2022

This bill requires the Food and Drug Administration to work through established processes to review and update internationally recognized standards for infant formula to ensure that such standards are consistent with standards applied to importing infant formula into the United States.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7718

Bill HR 7718 is currently in the status of Bill Introduced since May 11, 2022. Bill HR 7718 was introduced during Congress 117 and was introduced to the House on May 11, 2022. Bill HR 7718's most recent activity was Referred to the House Committee on Energy and Commerce. as of May 11, 2022

Bipartisan Support of Bill HR 7718

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7718

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7718

Formula Act of 2022

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to work through the Codex process to review and update internationally recognized standards for infant formula to ensure that such standards are consistent with the requirements applicable to the importation of infant formula into the United States.